Founders Capital Management Merck & Co., Inc. Transaction History

Founders Capital Management

$164 Million
Q3 2024

A detailed history of Founders Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Founders Capital Management holds 45,282 shares of MRK stock, worth $4.49 Million. This represents 3.14% of its overall portfolio holdings.

Number of Shares

45,282

Previous 44,554 1.63%

Holding current value

$4.49 Million

Previous $5.52 Million 6.76%

% of portfolio

3.14%

Previous 3.58%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$111.15 - $128.97 $80,917 - $93,890	728 Added 1.63%	45,282 $5.14 Million
Q2 2024 Jul 10, 2024	SELL	$123.8 - $132.96 $45,929 - $49,328	-371 Reduced 0.83%	44,554 $5.52 Million
Q1 2024 Apr 10, 2024	SELL	$113.24 - $131.95 $64,207 - $74,815	-567 Reduced 1.25%	44,925 $5.93 Million
Q4 2023 Jan 08, 2024	SELL	$100.18 - $109.02 $25,646 - $27,909	-256 Reduced 0.56%	45,492 $4.96 Million
Q3 2023 Oct 10, 2023	SELL	$102.95 - $114.33 $27,899 - $30,983	-271 Reduced 0.59%	45,748 $4.71 Million
Q2 2023 Jul 07, 2023	SELL	$108.61 - $118.38 $66,143 - $72,093	-609 Reduced 1.31%	46,019 $5.31 Million
Q1 2023 Apr 12, 2023	SELL	$102.94 - $114.86 $29,852 - $33,309	-290 Reduced 0.62%	46,628 $4.96 Million
Q4 2022 Jan 09, 2023	BUY	$87.44 - $112.11 $87 - $112	1 Added 0.0%	46,918 $5.21 Million
Q3 2022 Oct 06, 2022	SELL	$84.53 - $94.96 $29,078 - $32,666	-344 Reduced 0.73%	46,917 $4.04 Million
Q2 2022 Jul 20, 2022	BUY	$83.49 - $94.64 $1.88 Million - $2.13 Million	22,494 Added 90.82%	47,261 $4.31 Million
Q4 2021 Jan 21, 2022	SELL	$72.28 - $90.54 $43,223 - $54,142	-598 Reduced 2.36%	24,767 $1.9 Million
Q3 2021 Oct 12, 2021	SELL	$71.68 - $78.83 $148,736 - $163,572	-2,075 Reduced 7.56%	25,365 $1.91 Million
Q2 2021 Jul 15, 2021	BUY	$70.31 - $77.77 $34,100 - $37,718	485 Added 1.8%	27,440 $2.13 Million
Q1 2021 Jun 07, 2021	SELL	$68.86 - $81.11 $3,443 - $4,055	-50 Reduced 0.19%	26,955 $6,000
Q4 2020 Jan 12, 2021	SELL	$71.77 - $79.65 $226,434 - $251,295	-3,155 Reduced 10.46%	27,005 $2.21 Million
Q1 2020 Apr 22, 2020	SELL	$63.36 - $87.82 $73,497 - $101,871	-1,160 Reduced 3.7%	30,160 $2.32 Million
Q4 2019 Jan 24, 2020	BUY	$77.58 - $87.54 $378,590 - $427,195	4,880 Added 18.46%	31,320 $2.85 Million
Q3 2019 Oct 10, 2019	BUY	$76.08 - $82.93 $975,726 - $1.06 Million	12,825 Added 94.2%	26,440 $2.23 Million
Q4 2018 Jan 14, 2019	SELL	$65.24 - $75.71 $4,893 - $5,678	-75 Reduced 0.55%	13,615 $1.04 Million
Q2 2018 Jul 09, 2018	BUY	$50.83 - $59.72 $73,754 - $86,653	1,451 Added 11.86%	13,690 $831,000
Q1 2018 Apr 09, 2018	BUY	$50.96 - $59.23 $3,822 - $4,442	75 Added 0.62%	12,239 $667,000
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $713,661 - $767,913	12,164	12,164 $779,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management with notifications on news.

Account

Founders Capital Management Merck & Co., Inc. Transaction History